What is your treatment approach for a pediatric patient with H3K27M-mutant diffuse midline glioma following progression after radiation therapy?

First, if the patient is at least six months from initial radiation and had a reasonable initial response, reirradiation is the best proven treatment at recurrence. We would also encourage enrollment on a clinical trial (the DMG National Tumor Board is a helpful resource for determining for which tr...